Avalyn Pharma Inc 10-Q for FY2026 Q3
Avalyn Pharma Inc. (AVLN)
10-Q
2026-11-12
For: 2026-09-30
View Original
Added on
November 12, 2026
About this 10-Q
Avalyn Pharma Inc filed this 10-Q on November 12, 2026, covering the quarter ended September 30, 2026 (FY2026 Q3).
Avalyn Pharma reported a nine-month net loss of $85.5 million and $386.6 million in cash, cash equivalents and marketable securities as of September 30, 2026, which it expects to fund operations into 2029. AI summary
Headline figures
Quarter ended September 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $29.66M
- compared with a net loss of $23.58M a year earlier
- Diluted EPS
- -$0.67
- compared with -$20.34 a year earlier